The abundance of personal smartphones in southern African countries got University of Washington professor Sarah Gimbel thinking: What if these phones were used by front-line health workers — namely nurses — to collect and analyze data on patients living with HIV or AIDS to improve their care?
A new study by researchers of disease transmission in bats has broad implications for understanding hidden connections that can spread diseases between species and lead to large-scale outbreaks.
Project LifeSkills, a behavioral intervention to prevent HIV in young transgender women, was designated by the HIV/AIDS Prevention Research Synthesis (PRS) project at the U.S. Centers for Disease Control and Prevention (CDC) as showing the best evidence of efficacy.
The MidAtlantic AIDS Education and Training Center (MAAETC) will collaborate with UPMC and local HIV stakeholders to host an all-day educational forum to celebrate the 30th Anniversary of World AIDS Day and the 30th Anniversary of the MAAETC.
This month's Fred Hutch tip sheet includes story ideas about understanding how skin stops tumor growth, advances in studying Kasposi sarcoma, and forecasting the flu. To pursue any of these stories ideas, contact the person listed.
“Think globally, act locally” is a popular global health idea that encourages people to consider the health of the entire planet while taking actions in their own cities and communities. And it’s an idea that inspired a group of students in the Perelman School of Medicine to join with other medical schools in Philadelphia and start a group dedicated to the growing field of global surgery. Until recently, surgery has been largely omitted from global health efforts, taking a back seat to infectious diseases like HIV/AIDS, tuberculosis, and malaria. But as progress is made to treat and prevent these diseases, it has become clear that there is a significant need to focus on treating people in resource-limited settings who are in need of surgical care. And this need touches almost every aspect of health care from cancer to obstetrics to orthopedics. In fact, according to the Lancet Commission on Global Surgery, more than 18 million people die each year from lack of surgical care.
Biologists have discovered a new way of re-sensitizing drug-resistant tumor cells to DNA-damaging agents, the most widely used group of cancer drugs. Researchers describe how a gene known as Schlafen 11 controls the sensitivity of tumor cells to DDAs. Their research may pave the way to new strategies to overcome chemotherapeutic drug resistance.
In this issue, find research on infant sugary drink consumption, China's top 20 health challenges, aging and healthy years in the Netherlands, and increasing opioid use in Massachusetts
Audio from the American Neurological Association’s 143rd Annual Meeting media roundtable, held October 22, 2018, is now available. At the roundtable, presenters of the meeting’s six principal symposia presented highlights, discussed the relevance of the work, and answered questions.
The Midwest AIDS Training and Education Center (MATEC) at the University of Illinois at Chicago has received $4.4 million in funding from the federal government to advance its work improving HIV/AIDS care, prevention and education in Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, Ohio and Wisconsin.
FINDINGS Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus, or CMV. Infants who also were infected before birth by the virus that causes AIDS were especially prone to CMV infection. The researchers found that 23 percent of the infants who became infected with HIV during the mother’s pregnancy also were infected with CMV; 18 percent who were infected with HIV either during pregnancy or birth acquired congenital CMV; and 4.
Fear never works. Or does it? Fear can be a powerful tool in public health efforts, although graphic, emotionally evocative campaigns have been the source of controversy over the past half-century.
Researchers at the UNC School of Medicine have been awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to develop next generation, ultra-long-acting antiretroviral formulations for HIV treatment and prevention that have the potential to dramatically improve adherence.
Currently, a once-daily pill to prevent HIV infection is available. However, adherence to a once-daily regimen can be difficult for some people. Researchers from the UNC School of Medicine and the Centers for Disease Control and Prevention published a study today in Nature Communications that reports a potentially promising remedy for this problem.
A team of nurses and physicians has received a four-year, $3 million grant from the National Heart, Lung, and Blood Institute to extend traditional HIV treatment protocols to improve the cardiovascular health of people living with HIV.